Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease

Overview of attention for article published in Clinical Proteomics, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#20 of 334)
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 10,874 followers.

RT @kermitmurray: Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease https://t.co/g…

Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease https://t.co/gG6KD1fM4l #ClinProt #MassSpecPub

RT @realBioMassSpec: Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease #ClinProteo…

Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease #ClinProteomics https://t.co/EfjtBPG6BC

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.